Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.

The immunoglobulin heavy chain (IGH) gene rearrangement in chronic lymphocytic leukemia (CLL) provides a unique molecular signature; however, we demonstrate that 26/198 CLL patients (13%) had more than one IGH rearrangement, indicating the power of molecular technology over phenotypic analysis. Sing...

Full description

Bibliographic Details
Main Authors: Jitra Kriangkum, Sarah N Motz, Tanner Mack, Sara Beiggi, Eva Baigorri, Hemalatha Kuppusamy, Andrew R Belch, James B Johnston, Linda M Pilarski
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4564241?pdf=render
_version_ 1811342660350246912
author Jitra Kriangkum
Sarah N Motz
Tanner Mack
Sara Beiggi
Eva Baigorri
Hemalatha Kuppusamy
Andrew R Belch
James B Johnston
Linda M Pilarski
author_facet Jitra Kriangkum
Sarah N Motz
Tanner Mack
Sara Beiggi
Eva Baigorri
Hemalatha Kuppusamy
Andrew R Belch
James B Johnston
Linda M Pilarski
author_sort Jitra Kriangkum
collection DOAJ
description The immunoglobulin heavy chain (IGH) gene rearrangement in chronic lymphocytic leukemia (CLL) provides a unique molecular signature; however, we demonstrate that 26/198 CLL patients (13%) had more than one IGH rearrangement, indicating the power of molecular technology over phenotypic analysis. Single-cell PCR analysis and next-generation immuno-sequencing identified IGH-defined clones. In 23% (18/79) of cases whose clones carried unmutated immunoglobulin heavy chain variable (IGHV) genes (U-CLL), IGH rearrangements were bialleic with one productive (P) and one non-productive (NP) allele. Two U-CLL were biclonal, each clone being monoallelic (P). In 119 IGHV-mutated (M-CLL) cases, one had biallelic rearrangements in their CLL (P/NP) and five had 2-4 distinct clones. Allelic exclusion was maintained in all B-clones analyzed. Based on single-cell PCR analysis, 5/11 partner clones (45%) reached levels of >5x10(9) cells/L, suggesting second CLL clones. Partner clones persisted over years. Conventional IGH characterization and next-generation sequencing of 13 CLL, 3 multiple myeloma, 2 Waldenstrom's macroglobulinemia and 3 age-matched healthy donors consistently identified the same rearranged IGH sequences. Most multiple clones occurred in M-CLL, perhaps indicative of weak clonal dominance, thereby associating with a good prognosis. In contrast, biallelic CLL occurred primarily in U-CLL thus being associated with poor prognosis. Extending beyond intra-clonal diversity, molecular analysis of clonal evolution and apparent subclones in CLL may also reflect inter-clonal diversity.
first_indexed 2024-04-13T19:14:43Z
format Article
id doaj.art-7f4617d9519e44029a8c3809cf2e4678
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T19:14:43Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7f4617d9519e44029a8c3809cf2e46782022-12-22T02:33:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013723210.1371/journal.pone.0137232Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.Jitra KriangkumSarah N MotzTanner MackSara BeiggiEva BaigorriHemalatha KuppusamyAndrew R BelchJames B JohnstonLinda M PilarskiThe immunoglobulin heavy chain (IGH) gene rearrangement in chronic lymphocytic leukemia (CLL) provides a unique molecular signature; however, we demonstrate that 26/198 CLL patients (13%) had more than one IGH rearrangement, indicating the power of molecular technology over phenotypic analysis. Single-cell PCR analysis and next-generation immuno-sequencing identified IGH-defined clones. In 23% (18/79) of cases whose clones carried unmutated immunoglobulin heavy chain variable (IGHV) genes (U-CLL), IGH rearrangements were bialleic with one productive (P) and one non-productive (NP) allele. Two U-CLL were biclonal, each clone being monoallelic (P). In 119 IGHV-mutated (M-CLL) cases, one had biallelic rearrangements in their CLL (P/NP) and five had 2-4 distinct clones. Allelic exclusion was maintained in all B-clones analyzed. Based on single-cell PCR analysis, 5/11 partner clones (45%) reached levels of >5x10(9) cells/L, suggesting second CLL clones. Partner clones persisted over years. Conventional IGH characterization and next-generation sequencing of 13 CLL, 3 multiple myeloma, 2 Waldenstrom's macroglobulinemia and 3 age-matched healthy donors consistently identified the same rearranged IGH sequences. Most multiple clones occurred in M-CLL, perhaps indicative of weak clonal dominance, thereby associating with a good prognosis. In contrast, biallelic CLL occurred primarily in U-CLL thus being associated with poor prognosis. Extending beyond intra-clonal diversity, molecular analysis of clonal evolution and apparent subclones in CLL may also reflect inter-clonal diversity.http://europepmc.org/articles/PMC4564241?pdf=render
spellingShingle Jitra Kriangkum
Sarah N Motz
Tanner Mack
Sara Beiggi
Eva Baigorri
Hemalatha Kuppusamy
Andrew R Belch
James B Johnston
Linda M Pilarski
Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
PLoS ONE
title Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
title_full Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
title_fullStr Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
title_full_unstemmed Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
title_short Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
title_sort single cell analysis and next generation immuno sequencing show that multiple clones persist in patients with chronic lymphocytic leukemia
url http://europepmc.org/articles/PMC4564241?pdf=render
work_keys_str_mv AT jitrakriangkum singlecellanalysisandnextgenerationimmunosequencingshowthatmultipleclonespersistinpatientswithchroniclymphocyticleukemia
AT sarahnmotz singlecellanalysisandnextgenerationimmunosequencingshowthatmultipleclonespersistinpatientswithchroniclymphocyticleukemia
AT tannermack singlecellanalysisandnextgenerationimmunosequencingshowthatmultipleclonespersistinpatientswithchroniclymphocyticleukemia
AT sarabeiggi singlecellanalysisandnextgenerationimmunosequencingshowthatmultipleclonespersistinpatientswithchroniclymphocyticleukemia
AT evabaigorri singlecellanalysisandnextgenerationimmunosequencingshowthatmultipleclonespersistinpatientswithchroniclymphocyticleukemia
AT hemalathakuppusamy singlecellanalysisandnextgenerationimmunosequencingshowthatmultipleclonespersistinpatientswithchroniclymphocyticleukemia
AT andrewrbelch singlecellanalysisandnextgenerationimmunosequencingshowthatmultipleclonespersistinpatientswithchroniclymphocyticleukemia
AT jamesbjohnston singlecellanalysisandnextgenerationimmunosequencingshowthatmultipleclonespersistinpatientswithchroniclymphocyticleukemia
AT lindampilarski singlecellanalysisandnextgenerationimmunosequencingshowthatmultipleclonespersistinpatientswithchroniclymphocyticleukemia